No results found for “”
No results found for filter “”
-
EFPIA News 26.04.24
Journal article - Evolving assessment pathways for precision oncology medicines to improve patient access:...
This study describes challenges in assessing PO and TA medicines, explores possible solutions, and provides actionable recommendations to facilitate an...
Read Article -
EFPIA News 26.04.24
White paper on circular economy
Continued adoption of circular economy principles into the pharmaceutical sector can reduce materials extraction and operational waste, contribute to a...
Read Article -
Statements & press releases 25.04.24
Critical Medicines Alliance: A positive collaboration to enhance medicines supply chain security and...
EFPIA will work within the Alliance to help build resilience through a number of recommendations
Read Article -
Statements & press releases 22.04.24
EFPIA Statement on the use of AI in the medicinal product lifecycle in the context of the AI Act
It is critical that the regulatory frameworks governing the use of AI in research, development and manufacture must be fit-for-purpose, risk-based, non-duplicative,...
Read Article -
Statements & press releases 19.04.24
EFPIA swings behind Council’s call for a European Competitiveness Deal
Time to close the gap
Read Article -
Statements & press releases 17.04.24
Patient Information Leaflets: Putting Patients First
AESGP, EFPIA and Medicines for Europe publish joint recommendations for better patient information leaflets
Read Article -
Statements & press releases 11.04.24
EFPIA response to the European Parliament endorsement of the political agreement on UWWT directive
We support the overall objective of the revision to address water pollution, but we believe that every stakeholder must be part of any solution to enable...
Read Article -
Statements & press releases 10.04.24
EFPIA responds to the European Parliament plenary vote: Despite improvements, the Pharmaceutical Legislation...
Setting out how Europe sees the future of health and life science research and innovation, and patient care in the region.
Read Article -
Statements & press releases 09.04.24
Life science industry concerns over the workability of EU HTA: Europe cannot miss out on the opportunity...
We urge the Member States’ representatives to take into account these serious concerns from the innovative life science industry to ensure that the EU...
Read Article -
EFPIA News 28.03.24
NIRO: Navigating Innovation & Research Opportunities
NIRO helps you find available European and international funds for research & innovation.
Read Article -
Statements & press releases 28.03.24
Guidance needed to ensure EU Joint Clinical Assessment improves patient access to innovative cancer treatments...
New study simulating proposed EU HTA methods for oncology medicines underlines need for guidance on Joint Clinical Assessment process to help faster access...
Read Article -
Blog articles 26.03.24
Innovative Health Initiative: improving health, improving healthcare
From managing obesity to supporting healthier pregnancy, IHI is advancing people’s health and making health systems more efficient
Read Article
No results found for “”
No results found for filter “”
-
EFPIA News 26.04.24
Journal article - Evolving assessment pathways for precision oncology medicines to improve patient access:...
This study describes challenges in assessing PO and TA medicines, explores possible solutions, and provides actionable recommendations to facilitate an...
Read Article -
EFPIA News 26.04.24
White paper on circular economy
Continued adoption of circular economy principles into the pharmaceutical sector can reduce materials extraction and operational waste, contribute to a...
Read Article -
EFPIA News 28.03.24
NIRO: Navigating Innovation & Research Opportunities
NIRO helps you find available European and international funds for research & innovation.
Read Article -
EFPIA News 13.02.24
European business calls for deepening the EU Single Market and renewing the dynamic of European integration...
Read the joint statement from 26 trade associations.
Read Article -
EFPIA News 06.02.24
Recording Now Available: EJP RD-EFPIA Joint Advanced Webinar on Real-World Data, Machine Learning, and...
...
Read Article -
EFPIA News 27.10.23
Stefan Oelrich's interview at the POLITICO Health Care Summit
Watch the recording.
Read Article -
EFPIA News 15.10.23
EFPIA Japan Day 2023
With a delegation from EFPIA in Brussels, EFPIA Japan recently held “EFPIA Day” in Tokyo
Read Article -
EFPIA News 13.07.23
Joint Position Paper on the Hospital Exemption Scheme for ATMPs
Our organisations are committed to engage with policymakers and interested stakeholders for an inclusive and solutions-driven approach on the HE in the...
Read Article -
EFPIA News 13.07.23
Access to oncology combination therapies in Europe: Today's challenges and solutions
Despite the significant value combination therapies bring to cancer care, there are several challenges to their access in Europe. Without action, some...
Read Article -
EFPIA News 12.06.23
IHI Calls 4 and 5: Publication of draft topics and opening of registration to call days
IHI Call Days: Calls 4 & 5
Read Article -
EFPIA News 27.04.23
IHI seeks patients and caregivers to contribute to its activities
IHI is calling on patients and informal caregivers to apply to be part of a new IHI Patient Pool which will strengthen IHI’s ties with the patient community,...
Read Article -
EFPIA News 15.12.22
EFPIA survey among member companies on compliance with the EFPIA-PHRMA principles for responsible clinical...
EFPIA members continue to be committed to responsible clinical trial data sharing, for the benefit of patients and researchers
Read Article
No results found for “”
No results found for filter “”
-
Statements & press releases 25.04.24
Critical Medicines Alliance: A positive collaboration to enhance medicines supply chain security and...
EFPIA will work within the Alliance to help build resilience through a number of recommendations
Read Article -
Statements & press releases 22.04.24
EFPIA Statement on the use of AI in the medicinal product lifecycle in the context of the AI Act
It is critical that the regulatory frameworks governing the use of AI in research, development and manufacture must be fit-for-purpose, risk-based, non-duplicative,...
Read Article -
Statements & press releases 19.04.24
EFPIA swings behind Council’s call for a European Competitiveness Deal
Time to close the gap
Read Article -
Statements & press releases 17.04.24
Patient Information Leaflets: Putting Patients First
AESGP, EFPIA and Medicines for Europe publish joint recommendations for better patient information leaflets
Read Article -
Statements & press releases 11.04.24
EFPIA response to the European Parliament endorsement of the political agreement on UWWT directive
We support the overall objective of the revision to address water pollution, but we believe that every stakeholder must be part of any solution to enable...
Read Article -
Statements & press releases 10.04.24
EFPIA responds to the European Parliament plenary vote: Despite improvements, the Pharmaceutical Legislation...
Setting out how Europe sees the future of health and life science research and innovation, and patient care in the region.
Read Article -
Statements & press releases 09.04.24
Life science industry concerns over the workability of EU HTA: Europe cannot miss out on the opportunity...
We urge the Member States’ representatives to take into account these serious concerns from the innovative life science industry to ensure that the EU...
Read Article -
Statements & press releases 28.03.24
Guidance needed to ensure EU Joint Clinical Assessment improves patient access to innovative cancer treatments...
New study simulating proposed EU HTA methods for oncology medicines underlines need for guidance on Joint Clinical Assessment process to help faster access...
Read Article -
Statements & press releases 21.03.24
EFPIA signs the Antwerp Declaration
Driving Europe's competitiveness and resilience
Read Article -
Statements & press releases 20.03.24
Research based pharmaceutical industry calls on European Commission to develop comprehensive health and...
EFPIA response to the Commission’s Communication on Boosting Biotechnology and Biomanufacturing in the EU
Read Article -
Statements & press releases 19.03.24
EFPIA responds to ENVI adoption of the amendments to the Pharma-legislation
As MEPs vote on the amended text in the plenary session and discussions at the Council continue, EFPIA and its Members stress the need for continued dialogue...
Read Article -
Statements & press releases 13.03.24
Yes to EHDS, but not at any cost: EFPIA calls upon the EHDS trilogue negotiators to take sufficient time...
EFPIA reiterates its call to the co-legislators to take sufficient time for critical examination of the EHDS draft regulation or risk compromise on alternative...
Read Article
No results found for “”
No results found for filter “”
-
Blog articles 26.03.24
Innovative Health Initiative: improving health, improving healthcare
From managing obesity to supporting healthier pregnancy, IHI is advancing people’s health and making health systems more efficient
Read Article -
Blog articles 12.03.24
Reintegrating cancer patients into professional and social life (Guest blog)
People with certain cancers are living longer, fuller lives. We must come together to support their return to work
Read Article -
Blog articles 12.03.24
Healthcare innovation moves fast – so should the European regulatory system (Guest blog)
What will the innovations of tomorrow look like and how can they be regulated effectively without delaying access?
Read Article -
Blog articles 06.03.24
How to Unlock the Power of Drug Repurposing? EFPIA perspective
We propose principles to guide policies and legislations that will ensure safety and efficacy of repurposed drugs.
Read Article -
Blog articles 04.03.24
Make or break: The future of Regulatory Data Protection in Europe
When the Prime Minister of Belgium is calling for an Industrial Deal, when the Commission President has tasked former Italian Prime Minister Draghi to...
Read Article -
Blog articles 26.02.24
Imagining a future where rare diseases patients have a better chance at a healthy life
Past legislation has inspired impressive medicines development in Europe and we must continue to drive progress to deliver new, life-changing therapies...
Read Article -
Blog articles 26.02.24
For healthcare to be sustainable, it must work for innovators, healthcare systems and patients (Guest...
Properly designed policies can reward innovation, drive value and improve patients’ access to medicines.
Read Article -
Blog articles 21.02.24
EU HTA Implementation: Challenges, Commitments and Collective Actions (Guest blog)
There is less than one year to go before EU HTA is either a meaningful contributor to faster access for patients, and the foundation of a stronger and...
Read Article -
Blog articles 06.02.24
Patient engagement: accelerating progress in a spirit of partnership
Training, sharing best practices and measuring impact are key to moving patients centre stage, according to a survey of the EFPIA Patient Think Tank
Read Article -
Blog articles 22.01.24
From theory to therapy – MSD Policy Passport on Pharmaceutical Innovation (Guest blog)
Policy makers are in the driving seat. Their decisions play a key role in the creation and sustainability of Europe’s research and innovation ecosystem....
Read Article -
Blog articles 16.01.24
A new era for Precision Oncology: EFPIA’s vision for the future of cancer treatment in Europe beyond...
Envisioning a future where the potential of PO is not just theoretical but tangibly transformative necessitates aligning policy priorities and investments...
Read Article -
Blog articles 12.12.23
An Investment We Can't Ignore: Reflections on the Changing EU Pharmaceutical Landscape (Guest blog)
As Europe revises substantially its pharmaceutical legislative framework for the first time in 20 years, it remains critical that the region has the right...
Read Article